| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.089 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.098 | 0.6 |